IBD vs IBS: Different Disorders
Irritable bowel syndrome and inflammatory bowel disease may affect the same organ, but that’s pretty much where the similarities end.
Amitiza Studied for Chronic Constipation
While many people experience constipation at some point in time, some people have to deal with it on a much more regular basis. For these individuals, finding an effective treatment is very important.
Constipation Relief Without Serious Side Effects?
For people with chronic constipation, sometimes dietary changes like drinking more water and eating more fiber may not fully solve the problem. Researchers recently looked at one medication that may provide relief to people with chronic constipation without serious side effects.
Relief for Chronic Constipation
For individuals who experience chronic constipation, it can be a challenge to find an effective treatment out of the many options available. A recently published review points to some treatments that may work.
New Drug Application for Amitiza Approved
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. announced today that the FDA has approved Sucampo’s supplemental new drug application (sNDA) for AMITIZA ® (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.